AMANTADINE HYDROCHLORIDE IN THE TREATMENT OF PARKINSON'S DISEASE

1 October 1970

journal article
research article
Published by AMPCo in The Medical Journal of Australia

Vol. 2 (14), 634-637
https://doi.org/10.5694/j.1326-5377.1970.tb50241.x

Abstract

A double‐blind control trial of amantadine hydrochloride in a dosage of 200 mg per day, and placebo, each given for three weeks to 33 patients suffering from Parkinson's disease, confirms the results...

Keywords

TREATMENT
PARKINSON'S DISEASE
DOUBLE
AMANTADINE
ANTIPARKINSONIAN
HYDROCHLORIDE
TOLERATED
SMALLER
BENEFICIAL

This publication has 2 references indexed in Scilit:

AMANTADINE IN PARKINSONISM
The Lancet, 1970
CONTROLLED TRIAL OF AMANTADINE HYDROCHLORIDE IN PARKINSON'S DISEASE
The Lancet, 1970

Cited by 16 articles